Fairmount Funds Management LLC 13D and 13G filings for Kiniksa Pharmaceuticals, Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 3:45 pm Sale |
2024-12-31 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA |
Fairmount Funds Management LLC | 0 0.000% |
-3,204,841 (Position Closed) |
Filing |
| 2024-11-14 4:15 pm Purchase |
2024-09-30 | 13G | Kiniksa Pharmaceuticals, Ltd. KNSA |
Fairmount Funds Management LLC | 3,204,841 7.900% |
3,204,841 (New Position) |
Filing |